Semi-Annual Consolidated Statement Of Comprehensive Income

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7328365

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
4,447,740,000 JPY
5,517,708,000 JPY
4,447,740,000 JPY
4,447,740,000 JPY
4,447,740,000 JPY
5,024,027,000 JPY
5,024,027,000 JPY
5,024,027,000 JPY
5,024,027,000 JPY
6,050,708,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,047,725,000 JPY
2,425,940,000 JPY
Foreign currency translation adjustment
3,286,208,000 JPY
625,829,000 JPY
Share of other comprehensive income of entities accounted for using equity method
65,715,000 JPY
26,761,000 JPY
Other comprehensive income
4,399,649,000 JPY
3,078,531,000 JPY
Comprehensive income
9,917,358,000 JPY
9,129,240,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
9,932,461,000 JPY
9,141,113,000 JPY
Comprehensive income attributable to non-controlling interests
-15,103,000 JPY
-11,872,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.